<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_SCUT-China skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:SCUT-China</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="loadingLayer"><DIV id="loadingContainer"><H1>Loading</H1></DIV></DIV><DIV id="mainContainer"><NAV id="menuContainer"><UL id="menuNav"><LI><A href="https://2015.igem.org/Team:SCUT-China">HOME</A></LI><LI><A href="https://2015.igem.org/Team:SCUT-China/Team">TEAM</A></LI><LI><A href="https://2015.igem.org/Team:SCUT-China/Team">Team Members</A></LI><LI><A href="https://2015.igem.org/Team:SCUT-China/Attributions">Attribution</A></LI></UL><LI><A href="Description">PROJECT</A></LI><LI><A href="https://2015.igem.org/Team:SCUT-China/Description">Description</A></LI><LI><A href="https://2015.igem.org/Team:SCUT-China/Experiments">Experiments &amp; Results</A></LI><LI><A href="https://2015.igem.org/Team:SCUT-China/Protocols">Protocols</A></LI><LI><A href="https://2015.igem.org/Team:SCUT-China/Notebook">Notebook</A></LI><LI><A href="https://2015.igem.org/Team:SCUT-China/Parts">PARTS</A></LI><LI><A href="https://2015.igem.org/Team:SCUT-China/Collaborations">COLLABORATIONS</A></LI><LI><A href="https://2015.igem.org/Team:SCUT-China/Practices">HUMAN PRACTICES</A></LI><LI><A href="https://2015.igem.org/Team:SCUT-China/Practices">Overview</A></LI><LI><A href="https://2015.igem.org/Team:SCUT-China/hospitalInterview">Hospital Interview</A></LI><LI><A href="https://2015.igem.org/Team:SCUT-China/Conference">Seminar &amp; Conference</A></LI><LI><A href="https://2015.igem.org/Team:SCUT-China/dataAnalysis">Data Analysis</A></LI><LI><A href="https://2015.igem.org/Team:SCUT-China/criticalThinking">Law &amp; Regulation</A></LI><LI><A href="https://2015.igem.org/Team:SCUT-China/Safety">SAFETY</A></LI><LI><A href="https://2015.igem.org/Team:SCUT-China/Modeling">MODELING</A></LI></NAV><DIV id="indexContainer"><DIV id="overviewArea"><H2>Overview</H2><P>According to the data from WHO, cardiovascular diseases are the main leading cause of death globally. Cyclic guanosine monophosphate (cGMP) is a critical second messenger molecule.It can transduce nitric-oxide (NO) and natriuretic-peptide-coupled signaling and remit the myocardial hypertrophy by relaxing the blood vessels. This summer, we tried to use synthetic biology to modify the cGMP metabolic pathway in a human cell line.We hope that our work would provide the proof of principle for future gene therapy.</P><P>Soluble guanylate cyclase (sGC) is an enzyme that synthesize cGMP  from GTP. We up-regulate sGC by overexpressing its α and β subunits in a mammalian cell line. However, elevated levels of cGMP leads to the feed-back expression of PDE5a, a cGMP-specific phosphodiesteras that degrades cGMP. Thus, we further modified the pathway by silencing the PDE5a. To achieve controllable up-regulation of cGMP level in the cell, we designed a hypoxia-inducible operon, HRE, as a switch to up regulate cGMP only in hypoxia situation.</P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>